Drug Shortage Report for DEXAMETHASONE-OMEGA
Report ID | 255260 |
Drug Identification Number | 02204266 |
Brand name | DEXAMETHASONE-OMEGA |
Common or Proper name | DEXAMETHASONE PHOSPHATE INJECTION |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DEXAMETHASONE PHOSPHATE |
Strength(s) | 4MG |
Dosage form(s) | LIQUID |
Route of administration | SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR SOFT TISSUE INJECTION INTRAVENOUS INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10 X 25 mL vial / fiole |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2025-07-01 |
Actual start date | |
Estimated end date | 2025-07-31 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2025-05-02 |
Company comments | We are currently collaborating with Health Canada’s Drug Shortages Unit to mitigate any market impact. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | [email protected] - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-05-02 | French | Compare |
v4 | 2025-05-02 | English | Compare |
v3 | 2025-04-22 | English | Compare |
v2 | 2025-04-21 | French | Compare |
v1 | 2025-04-21 | English | Compare |
Showing 1 to 5 of 5